SIRT3 and pulmonary fibrosis: In addition, SIRT3 agonists (such as melatonin) can also alleviate PM2.5-induced aging and ferroptosis in mice, and targeting the USP3-SIRT3-P53 axis may provide new strategies for the treatment of pulmonary fibrosis (Li et al., 2023).